Tjong, M.C.; Ragulojan, M.; Poon, I.; Louie, A.V.; Cheng, S.Y.; Doherty, M.; Zhang, L.; Ung, Y.; Cheung, P.; Cheema, P.K.
Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience. Curr. Oncol. 2022, 29, 221-230.
https://doi.org/10.3390/curroncol29010021
AMA Style
Tjong MC, Ragulojan M, Poon I, Louie AV, Cheng SY, Doherty M, Zhang L, Ung Y, Cheung P, Cheema PK.
Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience. Current Oncology. 2022; 29(1):221-230.
https://doi.org/10.3390/curroncol29010021
Chicago/Turabian Style
Tjong, Michael C., Malavan Ragulojan, Ian Poon, Alexander V. Louie, Susanna Y. Cheng, Mark Doherty, Liying Zhang, Yee Ung, Patrick Cheung, and Parneet K. Cheema.
2022. "Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience" Current Oncology 29, no. 1: 221-230.
https://doi.org/10.3390/curroncol29010021
APA Style
Tjong, M. C., Ragulojan, M., Poon, I., Louie, A. V., Cheng, S. Y., Doherty, M., Zhang, L., Ung, Y., Cheung, P., & Cheema, P. K.
(2022). Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience. Current Oncology, 29(1), 221-230.
https://doi.org/10.3390/curroncol29010021
